Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- ALPHA.PA
- Price
- -
- Stock movement up
- +- (%)
- Company name
- Pharnext SA
- Exchange
- (PA ,
- Currency
- EUR )
- Sector
- Healthcare >Biotechnology
- Market cap
- 2.64K
- Ent value
- -
- Price/Sales
- -
- Price/Book
- -
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -
- 1 year return
- -99.98%
- 3 year return
- -100.00%
- 5 year return
- -99.94%
- 10 year return
- -
Last updated: 2025-08-27
DIVIDENDS
ALPHA.PA does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | - |
| Price to Book | - |
| EV to Sales | - |
FINANCIALS
STOCK INFORMATION
Downside potential
Loading...
Downside potential data
| ALPHA.PA | S&P500 | |
| Current price drop from All-time high | -100.00% | -0.01% |
| Highest price drop | -100.00% | -56.47% |
| Date of highest drop | 14 Feb 2025 | 9 Mar 2009 |
| Avg drop from high | -63.57% | -11.04% |
| Avg time to new high | 35 days | 12 days |
| Max time to new high | 1232 days | 1805 days |
COMPANY DETAILS
Marketcap
2.64K
Marketcap category
Small-cap
Description
Pharnext S.C.A., a clinical-stage biopharmaceutical company, engages in developing novel therapies for neurodegenerative diseases. Its products in clinical development include PXT3003, a synergistic combination of baclofen, naltrexone, and sorbitol formulated as an oral solution for the treatment of charcot-marie-tooth disease type 1A; and PXT864, a novel fixed-dose synergistic combination of baclofen and acamprosate formulated as a pill for neurodegenerative diseases. The company was incorporated in 2007 and is headquartered in Suresnes, France.
Employees
0
Website
Investor relations
-
SEC filings
CEO
Country
France
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
No items found